Ambria Capital

Healing Maps is a Miami-based mental health platform established in 2020, dedicated to providing education and information on psychedelic-assisted therapies, particularly focusing on ketamine treatment and other medical psychedelics. The company offers a comprehensive directory that helps individuals locate nearby clinics, alongside in-depth articles that deliver accurate and honest insights into the benefits and applications of psychedelic therapies for mental wellness. By empowering patients with the knowledge they need, Healing Maps aims to facilitate informed decisions regarding their mental health treatment options.

Tyson 2.0 is a cannabis company founded by renowned boxer and entrepreneur Mike Tyson, focused on producing high-quality cannabis products. The company offers a diverse range of offerings, including full-spectrum cannabis flower, concentrates, and consumables, which are designed to ensure both purity and precision. Tyson 2.0 aims to provide consumers with an exceptional selection that balances premium quality and affordability, making its products widely accessible at retailers across the nation.

Wonder Sciences operates an online telemedicine platform focused on mental health and wellness, using psychedelic-assisted therapies, novel therapeutic protocols, and neuroscience-based approaches to patient care. It collaborates with physicians to provide access to psychedelic medicines and related medical services, helping individuals with depression and anxiety pursue treatment from home or through affiliated clinics. The company also advances clinical research to develop evidence-based protocols and improve mental health care, overseeing care delivery and research efforts to expand safe, science-backed treatment options.

Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.

NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.

WeSana Health is a life sciences company focused on the advancement of psilocybin-based medicine. Founded in 2020 by Daniel Carcillo, the company is headquartered in Homer Glen, Illinois. WeSana Health is actively exploring new business opportunities to further its mission in the burgeoning field of psychedelics, aiming to develop innovative therapeutic solutions for various mental health conditions.

WeSana Health is a life sciences company focused on the advancement of psilocybin-based medicine. Founded in 2020 by Daniel Carcillo, the company is headquartered in Homer Glen, Illinois. WeSana Health is actively exploring new business opportunities to further its mission in the burgeoning field of psychedelics, aiming to develop innovative therapeutic solutions for various mental health conditions.